The Art Behind the Algorithm: Hybrid Ablation and the Need for a Lifetime Strategy in Non-Paroxysmal Atrial Fibrillation

The management of persistent and long-standing persistent atrial fibrillation remains highly variable in clinical practice, despite increasingly refined guidelines and an expanding ablation armamentarium. Treatment sequencing is frequently driven by local program infrastructure and institutional culture, and hybrid ablation is often deferred until multiple endocardial procedures have failed, by which point progressive atrial remodeling may have already narrowed the therapeutic window. Randomized and registry data support a meaningful role for hybrid ablation earlier in the disease course of selected patients with non-paroxysmal AF, particularly those with enlarged atria, prolonged AF duration, advanced substrate, or failed prior endocardial ablation. Contemporary pulsed-field ablation technology has improved procedural safety and efficiency, yet freedom from recurrence at one year in persistent AF remains substantially lower than in paroxysmal AF across all current energy platforms, reflecting the complexity of atrial substrate over time. This ongoing myocardial remodeling places non-paroxysmal AF closer to a chronic structural cardiac disease than to a discrete procedural target and demands a lifetime management strategy rather than a sequence of isolated procedural decisions. The mindset for other progressive structural cardiac diseases has already moved in this direction-aortic valve stenosis is now managed through a multidisciplinary team that integrates anatomy, timing, procedural durability, and long-term risk across the full patient trajectory. We propose an AF Heart Team framework for non-paroxysmal AF in which catheter-based, hybrid, and surgical strategies are selected according to disease phenotype and lifetime trajectory, with the goal of intervening before advanced remodeling reduces the likelihood of durable rhythm control.